Loading....
Coupon Accepted Successfully!

Orthopaedic

Open Flashcards

Metabolic Bone Diseases

Question
34 out of 42
 

Which of the following is used in osteoporosis for decreasing bone resorption and increasing bone formation.



A Teriparatide
B Calcitonin

C Strontium ranelate
D Bisphosphonate

Ans. C

Strontium ranelate

a. Teriparatide is the portion of human parathyroid hormone (PTH),

b. Teriparatide is the first FDA approved agent for the treatment of osteoporosis that stimulates new bone formation.

c. Strontium ranelate has been shown to decrease the risk of fractures in postmenopausal women. Its efficacy in clinical studies results from its unique mode of action, on both bone resorption and bone formation. resulting in increased bone mass

Metabolic Bone Diseases Flashcard List

42 flashcards
1)
2)
3)
4)
5)
6)
7)
8)
9)
10)
11)
12)
13)
14)
15)
16)
17)
18)
19)
20)
21)
22)
23)
24)
25)
26)
27)
28)
29)
30)
31)
32)
33)
34)
35)
36)
37)
38)
39)
40)
41)
42)